Inhibitors of Inducible Nitric Oxide Synthase Expression from Artemisia iwayomogi |
Ahn, Hanna
(College of Pharmacy, Sookmyung Womens University)
Kim, Ji-Yeon (College of Pharmacy, Sookmyung Womens University) Lee, Hwa-Jin (College of Pharmacy, Sookmyung Womens University) Kim, Yong-Kyun (College of Forest Science, Kookmin University) Ryu, Jae-Ha (College of Pharmacy, Sookmyung Womens University) |
1 | Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R., Analysis of nitrate, nitrite, and [] nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1982) DOI ScienceOn |
2 | Huneck, S., Zdero, C., and Bohlmann, F., Seco-guaianolides and other constituents from Artemisia species. Phytochemistry, 25, 883-889 (1986) DOI ScienceOn |
3 | Jin, M., Lee, H. J., Ryu, J.-H., and Chung, K. S., Inhibition of LPS-induced NO production and NF-B activation by a sesquiterpene from Saussurea lappa. Arch. Pharm. Res., 23, 54-58 (2000) DOI ScienceOn |
4 | Ryu, J.-H., Lee, H. J., Jeong, Y. S., Ryu, S. Y., and Han, Y. N., Yomogin, an inhibitor of nitric oxide production in LPSactivated macrophages. Arch. Pharm. Res., 21, 481-484 (1998) DOI ScienceOn |
5 | Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W. A., and Ziche, M., Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst., 90, 587-596 (1998) DOI ScienceOn |
6 | Ryu, J.-H., Jeong, Y. S., and Sohn, D. H., New bisabolene epoxide from Tussilago farfara and the inhibition of nitric oxide synthesis in LPS-activated macrophages. J. Nat. Prod., 62, 1437-1438 (1999) DOI ScienceOn |
7 | Ryu, J.-H., Son, H., Lee, S. H., and Sohn, D. H., Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-a expression in murine macrophage cell line RAW 264.7. Bioorg. Med. Chem. Let., 12, 649-651 (2001) DOI ScienceOn |
8 | Kilbourn, R. G. and Belloni, P., Endothelial cell production of nitrogen oxides in response to interferon in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natl. Cancer Inst., 82, 772-776 (1990) DOI PUBMED |
9 | Brouet, I. and Ohshima, H., Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun., 206, 533-540 (1995) DOI PUBMED ScienceOn |
10 | Ryu, J.-H., Han, B. H., Ahn, H., Lee, H. J., Feng, L., Qun, W. H., and Han, Y. N., Inhibitory activity of Chinese medicinal plants on nitric oxide synthesis in LPS-activated macrophages. J. Appl. Pharmacol., 9, 183-187 (2001) |
11 | Seo, H. J., Park, K. K., Han, S. S., Chung, W. Y., Son, M. W., Kim, W. B., and Surh, Y. J., Inhibitory effects of the standardized extract (DA-9601) of Artemisia asiatica Nakai on phorbol ester-induced ornithine decarboxylase activity, papilloma formation, cyclooxygenase-2 expression, inducible nitric oxide synthase expression and nuclear transcription factor kappa B activation in mouse skin. Int. J. Cancer, 100, 456-462 (2002) DOI ScienceOn |
12 | Thiemermann, C. and Vane, J., Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol., 182, 591-595 (1990) DOI ScienceOn |
13 | Bredt, D. S. and Snyder, S. H., Isolation of nitric oxide synthase, a calmoduline-requiring enzyme. Proc. Natl. Acad. Sci. USA, 87, 682-685 (1990) DOI ScienceOn |
14 | Lowenstein, C. J., Glatt, C. S., Bredt, D. S., and Snyder, S. H., Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA, 89, 6711-6715 (1992) DOI ScienceOn |
15 | Dong, Z., Staroselsky, A. H., Qi, X., Xie, K., and Fidler, I. J., Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res., 54, 789-793 (1994) PUBMED |
16 | Rao, C. V., Indranie, C., Simi, B., Manning, P. T., Connor, J. R., and Reddy, B. S., Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res., 62, 165-170 (2002) PUBMED |
17 | Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227, 680-685 (1970) DOI PUBMED ScienceOn |
18 | Oshima, H. and Bartsch, H., Chronic infectious and inflammation process as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Research, 305, 253-264 (1994) DOI PUBMED ScienceOn |
19 | Son, H. J., Lee, H. J., Yun-Choi, H. S., and Ryu, J.-H., Inhibitors of nitric oxide synthesis and TNF- expression from Magnolia obovata in activated macrophages. Planta Med., 66, 469-471 (2000) DOI ScienceOn |
20 | Oksuz, S., Sesquiterpenoids and other constituents from Tanacetum cilicium. Phytochemistry, 29, 887-890 (1990) DOI ScienceOn |
21 | Kang, T. H., Pae, H. O., Jeong, S. J., Yoo, J. C., Choi, B. M., Jun, C. D., Chung, H. T., Miyamoto, T., Higuchi, R., and Kim, Y. C., Scopoletin: an inducible nitric oxide synthesis inhibitory active constituent from Artemisia feddei. Planta Med., 65, 400-403 (1999) DOI ScienceOn |
22 | Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S., Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72, 41-44 (1995) DOI PUBMED ScienceOn |